According to Vericel
's latest financial reports the company has $0.22 B in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2023-12-31 | $0.22 B | 17.52% |
2022-12-31 | $0.19 B | 12.79% |
2021-12-31 | $0.17 B | 26.96% |
2020-12-31 | $0.13 B | 20.86% |
2019-12-31 | $0.11 B | 8.67% |
2018-12-31 | $0.10 B | 353.55% |
2017-12-31 | $22.54 M | -8.77% |
2016-12-31 | $24.7 M | 11.65% |
2015-12-31 | $22.13 M | -37.91% |
2014-12-31 | $35.64 M | 815.28% |
2013-12-31 | $3.89 M | -59.07% |
2012-12-31 | $9.51 M | -173.34% |
2011-12-31 | $-12.98 M | -543.91% |
2010-12-31 | $2.92 M | |
2010-06-30 | $17.79 M | 2.93% |
2009-06-30 | $17.28 M | -25.93% |
2008-06-30 | $23.33 M | -17.4% |
2007-06-30 | $28.25 M | -33.28% |
2006-06-30 | $42.34 M | 28.2% |
2005-06-30 | $33.02 M | 87.57% |
2004-06-30 | $17.6 M | 52.12% |
2003-06-30 | $11.57 M | 7.15% |
2002-06-30 | $10.8 M | -0.84% |
2001-06-30 | $10.89 M |
Company | Net assets | differencediff. | Country |
---|---|---|---|
Royalty Pharma RPRX | $10.08 B | 4,363.03% | ๐ฌ๐ง UK |
Neogen NEOG | $3.14 B | 1,292.41% | ๐บ๐ธ USA |